Ziegler, Jörn F.
Böttcher, Chotima http://orcid.org/0000-0002-6226-586X
Letizia, Marilena
Yerinde, Cansu
Wu, Hao
Freise, Inka
Rodriguez-Sillke, Yasmina http://orcid.org/0000-0001-7572-380X
Stoyanova, Ani K.
Kreis, Martin E.
Asbach, Patrick
Kunkel, Desiree http://orcid.org/0000-0002-0054-955X
Priller, Josef
Anagnostopoulos, Ioannis
Kühl, Anja A.
Miehle, Konstanze
Stumvoll, Michael
Tran, Florian
Fredrich, Broder
Forster, Michael http://orcid.org/0000-0001-9927-5124
Franke, Andre http://orcid.org/0000-0003-1530-5811
Bojarski, Christian
Glauben, Rainer
Löscher, Britt-Sabina http://orcid.org/0000-0001-9022-9017
Siegmund, Britta http://orcid.org/0000-0002-0055-958X
Weidinger, Carl http://orcid.org/0000-0002-9948-0088
Article History
Received: 9 July 2019
Accepted: 14 November 2019
First Online: 10 December 2019
Competing interests
: K.M. consulted for Aegerion Pharmaceuticals. B.S. has served as consultant for Abbvie, Boehringer, Celgene, Falk, Janssen, Lilly, Pfizer, Prometheus, Takeda and received speaker’s fees from Abbvie, CED Service GmbH, Falk, Ferring, Janssen, Novartis, Takeda (B.S. served as representative of the Charité). The remaining authors declare no competing interests.